Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)
CNY 18.83
(1.4%)
CNY 18.83
(1.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.88 Billion | 2.57 Billion | 2.27 Billion | 1.89 Billion | 1.65 Billion | 1.42 Billion |
| Cost of Revenue | 938.75 Million | 1.61 Billion | 1.36 Billion | 1.26 Billion | 1.13 Billion | 998.92 Million |
| Gross Profit | 943.7 Million | 964.27 Million | 907.16 Million | 633.63 Million | 517.22 Million | 425.65 Million |
| Operating Expenses | 736.76 Million | 753.45 Million | 724.58 Million | 478.02 Million | 398.13 Million | 318.33 Million |
| Selling, General and Administrative Expenses | 651 Million | 631.98 Million | 616.26 Million | 407.92 Million | 336.69 Million | 274.99 Million |
| Research and Development Expenses | 79.91 Million | 73.8 Million | 65.85 Million | 43.3 Million | 37.44 Million | 23.78 Million |
| Other Expenses | -5.83 Million | 47.67 Million | 42.46 Million | 26.79 Million | 23.99 Million | 153.35 Thousand |
| Cost and Expenses | 1.64 Billion | 2.36 Billion | 2.09 Billion | 1.73 Billion | 1.53 Billion | 1.31 Billion |
| Operating Income | 255.27 Million | 240.05 Million | 192.45 Million | 157.43 Million | 118.84 Million | 108.27 Million |
| Interest Expense | 1.4 Million | 890.22 Thousand | 1.35 Million | 244.64 Thousand | 1.14 Million | 2.59 Million |
| Income Tax Expense | 23.53 Million | 30.21 Million | 22.6 Million | 21.82 Million | 16.48 Million | 16.76 Million |
| Earnings before Tax | 257.41 Million | 239.82 Million | 194.83 Million | 156.94 Million | 121.62 Million | 108.42 Million |
| Net Income | 226.67 Million | 209.24 Million | 172.22 Million | 135.11 Million | 105.14 Million | 91.66 Million |
| Earnings Per Share Basic | 1.18 | 1.34 | 1.10 | 0.86 | 0.67 | 0.81 |
| Earnings Per Share Diluted | 1.18 | 1.34 | 1.10 | 0.86 | 0.67 | 0.81 |
| Weighted Average Shares Outstanding | 191.55 Million | 156.56 Million | 156.56 Million | 156.56 Million | 156.56 Million | 113.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 191.55 Million | 156.56 Million | 156.56 Million | 156.56 Million | 156.56 Million | 113.07 Million |
| Gross Margin | 0.50 | 0.37 | 0.40 | 0.33 | 0.31 | 0.30 |
| EBIT Margin | 0.16 | 0.11 | 0.10 | 0.09 | 0.08 | 0.09 |
| Profit Margin | 0.12 | 0.08 | 0.08 | 0.07 | 0.06 | 0.06 |
| EBITDA | 305.1 Million | 283.28 Million | 238.18 Million | 173.61 Million | 138.25 Million | 125.41 Million |
| Earnings Before Tax Margin | 0.14 | 0.09 | 0.08 | 0.08 | 0.07 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 350.79 Million | 428.84 Million | 333.61 Million | 1.88 Billion | 370.75 Million | 256.71 Million |
| Cost of Revenue | 119.35 Million | 123.06 Million | 103.39 Million | 938.75 Million | 111.06 Million | 93.67 Million |
| Gross Profit | 231.43 Million | 305.78 Million | 230.22 Million | 943.7 Million | 259.68 Million | 163.03 Million |
| Operating Expenses | 193.49 Million | 253.52 Million | 203.19 Million | 736.76 Million | 209.86 Million | 128.38 Million |
| Selling, General and Administrative Expenses | 176.92 Million | 234.08 Million | 176.45 Million | - | 182.23 Million | 131.65 Million |
| Research and Development Expenses | 17.07 Million | 11.95 Million | 23.54 Million | - | 23.92 Million | 17.13 Million |
| Other Expenses | 499.14 Thousand | -7.48 Million | -6776.25 | -5.83 Million | -3.7 Million | -53.04 Thousand |
| Cost and Expenses | 312.85 Million | 376.58 Million | 306.58 Million | 1.67 Billion | 320.92 Million | 222.06 Million |
| Operating Income | 37.94 Million | 52.26 Million | 29.01 Million | 206.94 Million | 49.82 Million | 44.31 Million |
| Interest Expense | 94.21 Thousand | 602.03 Thousand | 230.37 Thousand | 1.28 Million | 748.6 Thousand | -712.4 Thousand |
| Income Tax Expense | 4.71 Million | 9.39 Million | 1.55 Million | 23.53 Million | 5.45 Million | 2.55 Million |
| Earnings before Tax | 44.37 Million | 59.87 Million | 29 Million | 256.35 Million | 65.45 Million | 44.25 Million |
| Net Income | 41.54 Million | 47.05 Million | 30.37 Million | 226.67 Million | 55.29 Million | 40.24 Million |
| Earnings Per Share Basic | 0.22 | 0.25 | 0.19 | - | 0.35 | 0.26 |
| Earnings Per Share Diluted | 0.22 | 0.25 | 0.19 | - | 0.35 | 0.26 |
| Weighted Average Shares Outstanding | 189.85 Million | 189.85 Million | 159.85 Million | 157.6 Million | 157.6 Million | 157.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 189.85 Million | 189.85 Million | 159.85 Million | 157.6 Million | 157.6 Million | 157.64 Million |
| Gross Margin | 0.66 | 0.71 | 0.69 | 0.50 | 0.70 | 0.64 |
| EBIT Margin | 0.13 | 0.17 | 0.09 | - | 0.17 | 0.17 |
| Profit Margin | 0.12 | 0.11 | 0.09 | 0.12 | 0.15 | 0.16 |
| EBITDA | 44.47 Million | 71.52 Million | 31.12 Million | - | 63.39 Million | 42.96 Million |
| Earnings Before Tax Margin | 0.11 | 0.12 | 0.09 | 0.11 | 0.13 | 0.17 |
6024
267270
OEWA
RWMI
014825
GHBWF